Oral Cancer Treatment Market Synopsis:
The treatment for oral cancer is a
prime area of research as it is generally discovered late in its development.
Industry leaders are emphasizing on the development of more effective
diagnosis. Market Research Future (MRFR) has found out in its latest study that
the global oral cancer treatment market is anticipated to exhibit a CAGR of
7.1% during the forecast period 2019 to 2023. The need for early detection of
oral cancer is expected to boost the revenue growth of the market in the years
to come.
The increasing burden of the disease
is poised to catapult the oral cancer treatment market on an upward trajectory
in the nearby future. As per the statistics presented by the Oral Cancer Foundation,
53,000 Americans are estimated to be diagnosed with oral or oropharyngeal
cancer in 2019. Habits such as tobacco addiction trigger the rising risk of
developing oral cancer. Increasing cases of smoking addiction are anticipated
to propel the expansion of the oral cancer market in the forthcoming years.
The rising healthcare expenditure is
likely to influence the growth pattern of the market positively over the next
couple of years. On the contrary, the risk of recurrence of the disease,
coupled with the adverse effects associated with the treatment, remains an
impediment to market growth. In addition, the high cost of the treatment is
expected to check the proliferation of the oral cancer treatment market across
the review period.
Market Segmentation:
The global oral cancer treatment
market, by type, has been segmented into verrucous carcinoma, squamous cell
carcinoma, lymphomas, minor salivary gland carcinomas, and others.
On the basis of treatment, the oral
cancer treatment market has been segmented into surgery, chemotherapy,
radiotherapy, photodynamic therapy (PDT), and others. The surgery segment is
further sub-segmented into glossectomy, tumor resection, Mohs micrographic
surgery, laryngectomy, and others. The chemotherapy segment has been sub-segmented
into carboplatin, cisplatin, 5-fluorouracil (5-FU), and others.
Based on end-users,
the global oral cancer treatment market has been segmented into hospitals &
clinics, academic institutes, research organization, and others
No comments:
Post a Comment